Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
Nasopharyngeal infection by .

Proceedings of the National Academy of Sciences of the United States of America

Zeppa JJ, Kasper KJ, Mohorovic I, Mazzuca DM, Haeryfar SMM, McCormick JK.
PMID: 28794279
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10226-10231. doi: 10.1073/pnas.1700858114. Epub 2017 Aug 09.

The globally prominent pathogen

Cite
Zeppa JJ, Kasper KJ, Mohorovic I, et al. Nasopharyngeal infection by . Proc Natl Acad Sci U S A. 2017;114(38):10226-10231doi: 10.1073/pnas.1700858114.
Zeppa, J. J., Kasper, K. J., Mohorovic, I., Mazzuca, D. M., Haeryfar, S. M. M., & McCormick, J. K. (2017). Nasopharyngeal infection by . Proceedings of the National Academy of Sciences of the United States of America, 114(38), 10226-10231. https://doi.org/10.1073/pnas.1700858114
Zeppa, Joseph J, et al. "Nasopharyngeal infection by ." Proceedings of the National Academy of Sciences of the United States of America vol. 114,38 (2017): 10226-10231. doi: https://doi.org/10.1073/pnas.1700858114
Zeppa JJ, Kasper KJ, Mohorovic I, Mazzuca DM, Haeryfar SMM, McCormick JK. Nasopharyngeal infection by . Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10226-10231. doi: 10.1073/pnas.1700858114. Epub 2017 Aug 09. PMID: 28794279; PMCID: PMC5617250.
Copy Download .nbib Format: NLM
CD1d- and MR1-Restricted T Cells in Sepsis.

Frontiers in immunology

Szabo PA, Anantha RV, Shaler CR, McCormick JK, Haeryfar SM.
PMID: 26322041
Front Immunol. 2015 Aug 12;6:401. doi: 10.3389/fimmu.2015.00401. eCollection 2015.

Dysregulated immune responses to infection, such as those encountered in sepsis, can be catastrophic. Sepsis is typically triggered by an overwhelming systemic response to an infectious agent(s) and is associated with high morbidity and mortality even under optimal critical...

Cite
Szabo PA, Anantha RV, Shaler CR, et al. CD1d- and MR1-Restricted T Cells in Sepsis. Front Immunol. 2015;6:401doi: 10.3389/fimmu.2015.00401.
Szabo, P. A., Anantha, R. V., Shaler, C. R., McCormick, J. K., & Haeryfar, S. M. (2015). CD1d- and MR1-Restricted T Cells in Sepsis. Frontiers in immunology, 6401. https://doi.org/10.3389/fimmu.2015.00401
Szabo, Peter A, et al. "CD1d- and MR1-Restricted T Cells in Sepsis." Frontiers in immunology vol. 6 (2015): 401. doi: https://doi.org/10.3389/fimmu.2015.00401
Szabo PA, Anantha RV, Shaler CR, McCormick JK, Haeryfar SM. CD1d- and MR1-Restricted T Cells in Sepsis. Front Immunol. 2015 Aug 12;6:401. doi: 10.3389/fimmu.2015.00401. eCollection 2015. PMID: 26322041; PMCID: PMC4533011.
Copy Download .nbib Format: NLM
MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues.

Cancer immunology, immunotherapy : CII

Yao T, Rudak PT, Laumont CM, Michaud AR, Rashu R, Knier NN, Foster PJ, McWilliam HEG, Villadangos JA, Nelson BH, DiMattia GE, Shepherd TG, Haeryfar SMM.
PMID: 34854949
Cancer Immunol Immunother. 2021 Dec 02; doi: 10.1007/s00262-021-03118-9. Epub 2021 Dec 02.

The low mutational burden of epithelial ovarian cancer (EOC) is an impediment to immunotherapies that rely on conventional MHC-restricted, neoantigen-reactive T lymphocytes. Mucosa-associated invariant T (MAIT) cells are MR1-restricted T cells with remarkable immunomodulatory properties. We sought to characterize...

Cite
Yao T, Rudak PT, Laumont CM, et al. MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues. Cancer Immunol Immunother. 2021;doi: 10.1007/s00262-021-03118-9.
Yao, T., Rudak, P. T., Laumont, C. M., Michaud, A. R., Rashu, R., Knier, N. N., Foster, P. J., McWilliam, H. E. G., Villadangos, J. A., Nelson, B. H., DiMattia, G. E., Shepherd, T. G., & Haeryfar, S. M. M. (2021). MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues. Cancer immunology, immunotherapy : CII, . https://doi.org/10.1007/s00262-021-03118-9
Yao, Tony, et al. "MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues." Cancer immunology, immunotherapy : CII vol. (2021). doi: https://doi.org/10.1007/s00262-021-03118-9
Yao T, Rudak PT, Laumont CM, Michaud AR, Rashu R, Knier NN, Foster PJ, McWilliam HEG, Villadangos JA, Nelson BH, DiMattia GE, Shepherd TG, Haeryfar SMM. MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues. Cancer Immunol Immunother. 2021 Dec 02; doi: 10.1007/s00262-021-03118-9. Epub 2021 Dec 02. PMID: 34854949.
Copy Download .nbib Format: NLM
A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.

PLoS pathogens

Kim GN, Choi JA, Wu K, Saeedian N, Yang E, Park H, Woo SJ, Lim G, Kim SG, Eo SK, Jeong HW, Kim T, Chang JH, Seo SH, Kim NH, Choi E, Choo S, Lee S, Winterborn A, Li Y, Parham K, Donovan JM, Fenton B, Dikeakos JD, Dekaban GA, Haeryfar SMM, Troyer RM, Arts EJ, Barr SD, Song M, Kang CY.
PMID: 34914812
PLoS Pathog. 2021 Dec 16;17(12):e1010092. doi: 10.1371/journal.ppat.1010092. eCollection 2021 Dec.

The development of safe and effective vaccines to prevent SARS-CoV-2 infections remains an urgent priority worldwide. We have used a recombinant vesicular stomatitis virus (rVSV)-based prime-boost immunization strategy to develop an effective COVID-19 vaccine candidate. We have constructed VSV...

Cite
Kim GN, Choi JA, Wu K, et al. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2. PLoS Pathog. 2021;17(12):e1010092doi: 10.1371/journal.ppat.1010092.
Kim, G. N., Choi, J. A., Wu, K., Saeedian, N., Yang, E., Park, H., Woo, S. J., Lim, G., Kim, S. G., Eo, S. K., Jeong, H. W., Kim, T., Chang, J. H., Seo, S. H., Kim, N. H., Choi, E., Choo, S., Lee, S., Winterborn, A., Li, Y., Parham, K., Donovan, J. M., Fenton, B., Dikeakos, J. D., Dekaban, G. A., Haeryfar, S. M. M., Troyer, R. M., Arts, E. J., Barr, S. D., Song, M., & Kang, C. Y. (2021). A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2. PLoS pathogens, 17(12), e1010092. https://doi.org/10.1371/journal.ppat.1010092
Kim, Gyoung Nyoun, et al. "A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2." PLoS pathogens vol. 17,12 (2021): e1010092. doi: https://doi.org/10.1371/journal.ppat.1010092
Kim GN, Choi JA, Wu K, Saeedian N, Yang E, Park H, Woo SJ, Lim G, Kim SG, Eo SK, Jeong HW, Kim T, Chang JH, Seo SH, Kim NH, Choi E, Choo S, Lee S, Winterborn A, Li Y, Parham K, Donovan JM, Fenton B, Dikeakos JD, Dekaban GA, Haeryfar SMM, Troyer RM, Arts EJ, Barr SD, Song M, Kang CY. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2. PLoS Pathog. 2021 Dec 16;17(12):e1010092. doi: 10.1371/journal.ppat.1010092. eCollection 2021 Dec. PMID: 34914812; PMCID: PMC8675757.
Copy Download .nbib Format: NLM
The Future Liver Remnant in Patients Undergoing the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy (ALPPS) Maintains the Immunological Components of a Healthy Organ.

Frontiers in medicine

Anantha RV, Shaler CR, Meilleur CE, Parfitt J, Haeryfar SM, Hernandez-Alejandro R.
PMID: 27556025
Front Med (Lausanne). 2016 Aug 04;3:32. doi: 10.3389/fmed.2016.00032. eCollection 2016.

BACKGROUND AND AIMS: A short-interval, two-stage approach termed associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) increases the number of patients with extensive malignant disease of the liver and a small future liver remnant (FLR) that...

Cite
Anantha RV, Shaler CR, Meilleur CE, et al. The Future Liver Remnant in Patients Undergoing the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy (ALPPS) Maintains the Immunological Components of a Healthy Organ. Front Med (Lausanne). 2016;3:32doi: 10.3389/fmed.2016.00032.
Anantha, R. V., Shaler, C. R., Meilleur, C. E., Parfitt, J., Haeryfar, S. M., & Hernandez-Alejandro, R. (2016). The Future Liver Remnant in Patients Undergoing the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy (ALPPS) Maintains the Immunological Components of a Healthy Organ. Frontiers in medicine, 332. https://doi.org/10.3389/fmed.2016.00032
Anantha, Ram Venkatesh, et al. "The Future Liver Remnant in Patients Undergoing the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy (ALPPS) Maintains the Immunological Components of a Healthy Organ." Frontiers in medicine vol. 3 (2016): 32. doi: https://doi.org/10.3389/fmed.2016.00032
Anantha RV, Shaler CR, Meilleur CE, Parfitt J, Haeryfar SM, Hernandez-Alejandro R. The Future Liver Remnant in Patients Undergoing the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy (ALPPS) Maintains the Immunological Components of a Healthy Organ. Front Med (Lausanne). 2016 Aug 04;3:32. doi: 10.3389/fmed.2016.00032. eCollection 2016. PMID: 27556025; PMCID: PMC4972819.
Copy Download .nbib Format: NLM
A Highly Conserved Residue in HIV-1 Nef Alpha Helix 2 Modulates Protein Expression.

mSphere

Johnson AL, Dirk BS, Coutu M, Haeryfar SM, Arts EJ, Finzi A, Dikeakos JD.
PMID: 27840851
mSphere. 2016 Nov 09;1(6). doi: 10.1128/mSphere.00288-16. eCollection 2016.

Extensive genetic diversity is a defining characteristic of human immunodeficiency virus type 1 (HIV-1) and poses a significant barrier to the development of an effective vaccine. To better understand the impact of this genetic diversity on the HIV-1 pathogenic...

Cite
Johnson AL, Dirk BS, Coutu M, et al. A Highly Conserved Residue in HIV-1 Nef Alpha Helix 2 Modulates Protein Expression. mSphere. 2016;1(6)doi: 10.1128/mSphere.00288-16.
Johnson, A. L., Dirk, B. S., Coutu, M., Haeryfar, S. M., Arts, E. J., Finzi, A., & Dikeakos, J. D. (2016). A Highly Conserved Residue in HIV-1 Nef Alpha Helix 2 Modulates Protein Expression. mSphere, 1(6), . https://doi.org/10.1128/mSphere.00288-16
Johnson, Aaron L, et al. "A Highly Conserved Residue in HIV-1 Nef Alpha Helix 2 Modulates Protein Expression." mSphere vol. 1,6 (2016). doi: https://doi.org/10.1128/mSphere.00288-16
Johnson AL, Dirk BS, Coutu M, Haeryfar SM, Arts EJ, Finzi A, Dikeakos JD. A Highly Conserved Residue in HIV-1 Nef Alpha Helix 2 Modulates Protein Expression. mSphere. 2016 Nov 09;1(6). doi: 10.1128/mSphere.00288-16. eCollection 2016. PMID: 27840851; PMCID: PMC5103047.
Copy Download .nbib Format: NLM
A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.

PLoS pathogens

Kim GN, Choi JA, Wu K, Saeedian N, Yang E, Park H, Woo SJ, Lim G, Kim SG, Eo SK, Jeong HW, Kim T, Chang JH, Seo SH, Kim NH, Choi E, Choo S, Lee S, Winterborn A, Li Y, Parham K, Donovan JM, Fenton B, Dikeakos JD, Dekaban GA, Haeryfar SMM, Troyer RM, Arts EJ, Barr SD, Song M, Kang CY.
PMID: 34914812
PLoS Pathog. 2021 Dec 16;17(12):e1010092. doi: 10.1371/journal.ppat.1010092. eCollection 2021 Dec.

The development of safe and effective vaccines to prevent SARS-CoV-2 infections remains an urgent priority worldwide. We have used a recombinant vesicular stomatitis virus (rVSV)-based prime-boost immunization strategy to develop an effective COVID-19 vaccine candidate. We have constructed VSV...

Cite
Kim GN, Choi JA, Wu K, et al. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2. PLoS Pathog. 2021;17(12):e1010092doi: 10.1371/journal.ppat.1010092.
Kim, G. N., Choi, J. A., Wu, K., Saeedian, N., Yang, E., Park, H., Woo, S. J., Lim, G., Kim, S. G., Eo, S. K., Jeong, H. W., Kim, T., Chang, J. H., Seo, S. H., Kim, N. H., Choi, E., Choo, S., Lee, S., Winterborn, A., Li, Y., Parham, K., Donovan, J. M., Fenton, B., Dikeakos, J. D., Dekaban, G. A., Haeryfar, S. M. M., Troyer, R. M., Arts, E. J., Barr, S. D., Song, M., & Kang, C. Y. (2021). A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2. PLoS pathogens, 17(12), e1010092. https://doi.org/10.1371/journal.ppat.1010092
Kim, Gyoung Nyoun, et al. "A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2." PLoS pathogens vol. 17,12 (2021): e1010092. doi: https://doi.org/10.1371/journal.ppat.1010092
Kim GN, Choi JA, Wu K, Saeedian N, Yang E, Park H, Woo SJ, Lim G, Kim SG, Eo SK, Jeong HW, Kim T, Chang JH, Seo SH, Kim NH, Choi E, Choo S, Lee S, Winterborn A, Li Y, Parham K, Donovan JM, Fenton B, Dikeakos JD, Dekaban GA, Haeryfar SMM, Troyer RM, Arts EJ, Barr SD, Song M, Kang CY. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2. PLoS Pathog. 2021 Dec 16;17(12):e1010092. doi: 10.1371/journal.ppat.1010092. eCollection 2021 Dec. PMID: 34914812.
Copy Download .nbib Format: NLM
Editorial: CD1- and MR1-Restricted T Cells in Antimicrobial Immunity.

Frontiers in immunology

Haeryfar SM, Mallevaey T.
PMID: 26697007
Front Immunol. 2015 Dec 02;6:611. doi: 10.3389/fimmu.2015.00611. eCollection 2015.

No abstract available.

Cite
Haeryfar SM, Mallevaey T. Editorial: CD1- and MR1-Restricted T Cells in Antimicrobial Immunity. Front Immunol. 2015;6:611doi: 10.3389/fimmu.2015.00611.
Haeryfar, S. M., & Mallevaey, T. (2015). Editorial: CD1- and MR1-Restricted T Cells in Antimicrobial Immunity. Frontiers in immunology, 6611. https://doi.org/10.3389/fimmu.2015.00611
Haeryfar, S M Mansour, and Mallevaey, Thierry. "Editorial: CD1- and MR1-Restricted T Cells in Antimicrobial Immunity." Frontiers in immunology vol. 6 (2015): 611. doi: https://doi.org/10.3389/fimmu.2015.00611
Haeryfar SM, Mallevaey T. Editorial: CD1- and MR1-Restricted T Cells in Antimicrobial Immunity. Front Immunol. 2015 Dec 02;6:611. doi: 10.3389/fimmu.2015.00611. eCollection 2015. PMID: 26697007; PMCID: PMC4666986.
Copy Download .nbib Format: NLM
Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study.

CMAJ open

Anantha RV, Jegatheswaran J, Pepe DL, Priestap F, Delport J, Haeryfar SM, McCormick JK, Mele T.
PMID: 25553328
CMAJ Open. 2014 Oct 01;2(4):E352-9. doi: 10.9778/cmajo.20140018. eCollection 2014 Oct.

INTRODUCTION: Staphylococcus aureus bacteremia is associated with significant morbidity and mortality. Given the paucity of recent Canadian data, we estimated the mortality rate associated with S. aureus bacteremia in a tertiary care hospital and identified risk factors associated with...

Cite
Anantha RV, Jegatheswaran J, Pepe DL, et al. Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study. CMAJ Open. 2014;2(4):E352-9doi: 10.9778/cmajo.20140018.
Anantha, R. V., Jegatheswaran, J., Pepe, D. L., Priestap, F., Delport, J., Haeryfar, S. M., McCormick, J. K., & Mele, T. (2014). Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study. CMAJ open, 2(4), E352-9. https://doi.org/10.9778/cmajo.20140018
Anantha, Ram Venkatesh, et al. "Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study." CMAJ open vol. 2,4 (2014): E352-9. doi: https://doi.org/10.9778/cmajo.20140018
Anantha RV, Jegatheswaran J, Pepe DL, Priestap F, Delport J, Haeryfar SM, McCormick JK, Mele T. Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study. CMAJ Open. 2014 Oct 01;2(4):E352-9. doi: 10.9778/cmajo.20140018. eCollection 2014 Oct. PMID: 25553328; PMCID: PMC4270209.
Copy Download .nbib Format: NLM
Manipulation of Innate and Adaptive Immunity by Staphylococcal Superantigens.

Pathogens (Basel, Switzerland)

Tuffs SW, Haeryfar SMM, McCormick JK.
PMID: 29843476
Pathogens. 2018 May 29;7(2). doi: 10.3390/pathogens7020053.

Staphylococcal superantigens (SAgs) constitute a family of potent exotoxins secreted by

Cite
Tuffs SW, Haeryfar SMM, McCormick JK. Manipulation of Innate and Adaptive Immunity by Staphylococcal Superantigens. Pathogens. 2018;7(2)doi: 10.3390/pathogens7020053.
Tuffs, S. W., Haeryfar, S. M. M., & McCormick, J. K. (2018). Manipulation of Innate and Adaptive Immunity by Staphylococcal Superantigens. Pathogens (Basel, Switzerland), 7(2), . https://doi.org/10.3390/pathogens7020053
Tuffs, Stephen W, et al. "Manipulation of Innate and Adaptive Immunity by Staphylococcal Superantigens." Pathogens (Basel, Switzerland) vol. 7,2 (2018). doi: https://doi.org/10.3390/pathogens7020053
Tuffs SW, Haeryfar SMM, McCormick JK. Manipulation of Innate and Adaptive Immunity by Staphylococcal Superantigens. Pathogens. 2018 May 29;7(2). doi: 10.3390/pathogens7020053. PMID: 29843476; PMCID: PMC6027230.
Copy Download .nbib Format: NLM
Long Non-Coding RNA TRG-AS1 Promoted Proliferation and Invasion of Lung Cancer Cells Through the miR-224-5p/SMAD4 Axis.

OncoTargets and therapy

Zhang M, Zhu W, Haeryfar M, Jiang S, Jiang X, Chen W, Li J.
PMID: 34408438
Onco Targets Ther. 2021 Aug 10;14:4415-4426. doi: 10.2147/OTT.S297336. eCollection 2021.

INTRODUCTION: The aim of this study was to investigate the role and mechanism of long non-coding RNA (lncRNA) TRG-AS1 in mediating the proliferation, invasion and migration of lung cancer cells as well lung tumor growth.METHODS: Firstly, the expression levels...

Cite
Zhang M, Zhu W, Haeryfar M, et al. Long Non-Coding RNA TRG-AS1 Promoted Proliferation and Invasion of Lung Cancer Cells Through the miR-224-5p/SMAD4 Axis. Onco Targets Ther. 2021;14:4415-4426doi: 10.2147/OTT.S297336.
Zhang, M., Zhu, W., Haeryfar, M., Jiang, S., Jiang, X., Chen, W., & Li, J. (2021). Long Non-Coding RNA TRG-AS1 Promoted Proliferation and Invasion of Lung Cancer Cells Through the miR-224-5p/SMAD4 Axis. OncoTargets and therapy, 144415-4426. https://doi.org/10.2147/OTT.S297336
Zhang, Mengyan, et al. "Long Non-Coding RNA TRG-AS1 Promoted Proliferation and Invasion of Lung Cancer Cells Through the miR-224-5p/SMAD4 Axis." OncoTargets and therapy vol. 14 (2021): 4415-4426. doi: https://doi.org/10.2147/OTT.S297336
Zhang M, Zhu W, Haeryfar M, Jiang S, Jiang X, Chen W, Li J. Long Non-Coding RNA TRG-AS1 Promoted Proliferation and Invasion of Lung Cancer Cells Through the miR-224-5p/SMAD4 Axis. Onco Targets Ther. 2021 Aug 10;14:4415-4426. doi: 10.2147/OTT.S297336. eCollection 2021. PMID: 34408438; PMCID: PMC8364376.
Copy Download .nbib Format: NLM
Physical restraint mouse models to assess immune responses under stress with or without habituation.

STAR protocols

Ding JX, Rudak PT, Inoue W, Haeryfar SMM.
PMID: 34568850
STAR Protoc. 2021 Sep 14;2(4):100838. doi: 10.1016/j.xpro.2021.100838. eCollection 2021 Dec 17.

Physical confinement, or restraint, is a psychological stressor used in rodent studies. A single restraint episode elevates blood corticosterone levels, a hallmark of stress responses. Repeated restraint results in habituation (or desensitization), whereas chronic exposure to unpredictable stressors fails...

Cite
Ding JX, Rudak PT, Inoue W, et al. Physical restraint mouse models to assess immune responses under stress with or without habituation. STAR Protoc. 2021;2(4):100838doi: 10.1016/j.xpro.2021.100838.
Ding, J. X., Rudak, P. T., Inoue, W., & Haeryfar, S. M. M. (2021). Physical restraint mouse models to assess immune responses under stress with or without habituation. STAR protocols, 2(4), 100838. https://doi.org/10.1016/j.xpro.2021.100838
Ding, Jian Xiang, et al. "Physical restraint mouse models to assess immune responses under stress with or without habituation." STAR protocols vol. 2,4 (2021): 100838. doi: https://doi.org/10.1016/j.xpro.2021.100838
Ding JX, Rudak PT, Inoue W, Haeryfar SMM. Physical restraint mouse models to assess immune responses under stress with or without habituation. STAR Protoc. 2021 Sep 14;2(4):100838. doi: 10.1016/j.xpro.2021.100838. eCollection 2021 Dec 17. PMID: 34568850; PMCID: PMC8449122.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries